Articles tagged with Bacterial Infections
The study found that P. aeruginosa adapts to the lung's mucus by relying on sugars and lactate, but also needs to synthesize essential nutrients through metabolic independence. Biofilm formation imposes a metabolic burden, slowing down the bacteria's ability to spread, while disrupting biofilms makes them more vulnerable to antibiotics.
Researchers designed a skin patch that uses imperceptible electric currents to control microbes, stopping 99% of biofilm formation in bacteria. The device, called Bioelectronic Localized Antimicrobial Stimulation Therapy, could lead to a wearable patch with a wireless circuit to control infections without drugs.
A study by FSU researchers has found a potential link between an infection caused by gut bacteria and the progression of Alzheimer's disease. The research suggests that antibiotic exposure can lead to issues not just in the gut but also in the brain, triggering neuroinflammation and neurocognitive impairment.
Researchers developed a nanomedicine that attacks bacteria at the molecular level, reducing antibiotic resistance and side effects. The technology releases medication only when required, ensuring patients take exact amounts to fight infections.
Researchers at Aarhus University have decoded part of the bacterial defense mechanism against antibiotics, providing a crucial step towards treating resistant MRSA infections. Understanding the molecular composition of the biofilm-forming protein PSMα1 could lead to new strategies and treatments to prevent biofilm formation.
The study describes the full molecular structure of the phage DEV, which infects and lysates Pseudomonas aeruginosa bacteria. The researchers discovered a genome ejection motor that pulls the DNA out of its head after infection, with conserved design principles across all Schitoviridae phages.
Researchers have identified a new group of bacterial toxins that can destroy cells of bacteria and fungi without harming other organisms. The study reveals how these toxins are used by bacteria to compete with other microbes, offering exciting possibilities for clinical and biotechnological applications.
Researchers discovered a new species of bacteria, Hardy ecospecies, that thrives on carnivore diets, contradicting the long-held assumption that modern humans are omnivores. The study found genetic variations in bacteria that inform us about our ancestors' diet.
A team of researchers from the University of Florida Health has been awarded a significant grant to explore the use of combination antibiotics to combat antibiotic-resistant bacteria. The study aims to understand the molecular mechanisms behind bacterial resistance and develop new treatment strategies to tackle deadly superbugs.
A new study reveals that fecal microbiota transplants can increase Lachnospiraceae bacteria, which outcompete C. diff for resources and alter bile acids to create an environment favorable for other good bacteria to thrive.
A team of HKU chemists has made a breakthrough in combating antibiotic-resistant bacteria by combining bismuth-based drugs with antibiotics. This synergistic approach disrupts bacterial iron homeostasis, effectively eliminating multi-drug resistant Pseudomonas aeruginosa infections.
Scientists have found a way to pinpoint single bacteria that are resistant to antibiotics, making it easier to choose the right treatment. This breakthrough could lead to improved treatment outcomes for patients with Staphylococcus aureus infections.
A new study has identified the genetic elements responsible for transforming classical Klebsiella pneumoniae into a devastating, drug-resistant killer. Researchers found that the plasmid pVir is the primary determinant of hypervirulence in this bacterium.
A team of researchers at UMC Utrecht has identified 29 novel antibodies against the bacterium Klebsiella pneumoniae, an important cause of drug-resistant infections. The antibodies were found to interact with antigens on the bacterial surface and some act synergistically to neutralize the pathogen.
Researchers developed a nasal spray that captures and neutralizes airborne viruses and bacteria, providing up to 8 hours of protection. The Pathogen Capture and Neutralizing Spray (PCANS) demonstrated a greater than 99.99% reduction in lung viral titers in mice models.
Researchers have developed an antibody that can identify Campylobacter jejuni and inhibit its growth, reducing pathogenicity. The antibody targets a multiprotein complex essential for the bacteria's energy production, making it a potential target for therapy and vaccination.
A proof-of-concept study introduces a medical device that measures protease activity in human breath to diagnose lower respiratory tract infections. The system showed elevated levels of human neutrophil elastase in patients with confirmed lower respiratory tract infections, suggesting its potential for rapid and non-invasive diagnosis.
Researchers at Chalmers University of Technology have developed a graphene-based, ultra-thin antibacterial material that can kill 99.9% of bacteria on surfaces, including medical devices and implants. The new technology uses fridge magnet technology to control the orientation of graphene flakes, making it possible for practical applica...
A Virginia Tech research team has identified a molecular mechanism by which Shigella flexneri bacteria manipulate host molecules to ensure their survival. The study provides a new understanding of the infection pathway and its potential implications for preventing similar infections in other bacteria.
Researchers have conducted the largest genomic survey of the syphilis bacterium to date, correlating genetic data with clinical information to identify potential targets for a vaccine. The study found differences in bacterial strains between continents, but also similarities that suggest a global vaccine could be effective.
A recent study published in Cell Reports Medicine has discovered an important immune component that offers protection against MRSA infection. The researchers found that IgM antibodies are required for clearance of S. aureus during an infection, suggesting a new direction for future vaccine strategies and therapies.
A new monoclonal antibody drug has been developed to prevent infection with A. baumannii, a common cause of hospital-acquired infections. The treatment was shown to be effective in reducing bacterial load in mice, and could potentially become a powerful new weapon against antimicrobial resistance.
Researchers will conduct laboratory and field work at UC Medical Center to detect airborne transmission of MRSA. The study aims to better understand the significance of airborne transmission of MRSA and inform enhanced workplace safety measures.
Repeated antibiotic use can cause defects in the gut's protective mucus barrier, even months after treatment. This is due to changes in the microbiota or direct effects of antibiotics on the mucus layer. The findings suggest that antibiotics should be used responsibly to prevent long-lasting damage.
Acinetobacter baumannii is a highly resistant bacterial species causing serious infections. Researchers have engineered mutant strains to study anti-Acinetobacter compounds and address AMR preparedness.
A study by Virginia Tech undergraduate Megan O'Hara found that surface properties significantly influence bacterial twitching motility, allowing for rapid colonization and infection. By manipulating surface properties with detergents like bile salts, researchers can alter the functionality of type IV pili, a critical virulence factor.
A new study found that higher BMI is associated with hospitalization for severe bacterial and viral infections. Conversely, mild hyperglycemia was not linked to increased risk of severe infections.
A study of 500,000 UK participants found insulin resistance associated with higher risk of 26 conditions, such as sleep disorders and pancreatitis, and lower risk of five diseases, including anaemia and Parkinson's disease. Insulin resistance also linked to increased mortality risk in women.
A study on the UK E. coli outbreak identified contaminated lettuce as the primary source of infection, with heavy rainfall carrying STEC from animal feces to the crops. The investigation demonstrated the value of a One Health approach in predicting and preventing future outbreaks.
Researchers developed an algorithm to analyze peptides in infected wounds, revealing unique biomarkers that enable earlier and more accurate diagnoses. This breakthrough method uses mass spectrometry and machine learning to diagnose infections in just a few minutes.
A recent study has revealed that oral bacteria, specifically Aggregatibacter actinomycetemcomitans, can exacerbate rheumatoid arthritis. The study found that the infection led to increased inflammation and joint damage in animal models.
Researchers at Gladstone Institutes have developed a streamlined way to engineer bacteriophages, viruses that naturally kill bacteria. The new technique uses retrons to edit phage genomes, allowing for the creation of numerous variants and paving the way for alternative treatments for antibiotic-resistant infections.
The new guideline updates treatment recommendations for Helicobacter pylori infection, shifting away from proton pump inhibitor-clarithromycin triple therapy. Bismuth quadruple therapy and other alternatives are now recommended for treatment-naïve patients.
Researchers at the University of Sheffield discovered a new sensory capability in bacteria that enables them to directly sense their chemical environment. This breakthrough could lead to innovative treatments that manipulate bacterial motility to enhance antibiotic efficacy.
A subset of CD4 T cells create an anti-inflammatory environment within the lung tissue, protecting against TB reinfection by limiting bacterial growth and disease severity. The discovery complements previous research on protective immune T cells in controlling TB infection, suggesting a potential key to improving existing vaccines.
Scientists have created a new chemical probe to visualize the distribution of sphingomyelin and its degradation by sphingomyelinase during infections. The researchers observed increased metabolization of sphingomyelin molecules during Chlamydia infection, paving the way for targeted strategies against infectious diseases.
Researchers have successfully infected gastrointestinal epithelial cells with Chlamydia trachomatis using lab-grown human organoids. This finding supports the theory that Chlamydia can form a reservoir in the human gut, highlighting the importance of further investigation into this potential reservoir.
Researchers developed a new 'pan-pathogen' deep sequencing approach to capture multiple bacterial strains simultaneously. This method enables faster and more comprehensive tracking of antibiotic-resistant bacteria, potentially preventing and managing common hospital infections quicker.
A team of researchers at UC Davis Health discovered a novel bioelectrical mechanism that allows Salmonella bacteria to navigate the gut lining and find vulnerable entry points. The study found that Salmonella bacteria detect electric signals in FAE, which helps them move towards openings in the gut where they can enter.
Researchers have discovered that oleic acid, a naturally occurring oil in the body, restores a healthy balance of vaginal microbes in a laboratory model of BV. Oleic acid inhibits growth of detrimental bacteria and promotes healthier species associated with a stable microbiome.
Researchers at The University of Warwick created a realistic model of ventilator-associated pneumonia (VAP) to better understand the infection. The study found that combining antibiotics with enzymes that break down biofilm slime layers could successfully eradicate the bacteria, offering new hope for treatments.
A genetic analysis of Lyme disease bacteria has created a powerful resource for identifying specific bacterial strains, enabling more accurate diagnostic tests and treatments. The study reveals how these bacteria evolve and exchange genetic material, providing insights for predicting and responding to changes in their behavior.
A study analyzing 5.5 million EU/EEA infectious disease cases over 10 years found significant sex differences in notified male versus female cases for several diseases. The proportion of males ranged from 40-45% for pertussis and Shiga toxin-producing Escherichia coli infections to 75-80% for HIV/AIDS.
A study published in PLOS Water found associations between weather, geographic location, and urban/rural settings with waterborne infectious disease hospitalizations. Hospitalization rates were higher for enteric and biofilm-forming bacterial pathogens in areas using groundwater, while precipitation increased parasitic infections.
A study found that hospitalization of a relative increases the risk of MRSA infection in household members. The longer the relative's hospital stay, the higher the risk. Researchers recommend enhanced infection control practices to track and mitigate transmission.
Researchers at WashU Medicine have developed a novel compound that effectively clears bacterial infections in mice, including those causing rare and potentially fatal 'flesh-eating' illnesses. The compound targets gram-positive bacteria, reducing virulence and speeding up post-infection healing.
A new study found that heteroresistance, a phenomenon where a tiny fraction of bacteria remain resistant to antibiotics, is also present in fungal bloodstream infections in bone marrow transplant patients. The research identified the specific species of fungi responsible and developed a machine learning model to detect this type of inf...
A study identified a protein called IL-22BP that affects the composition of gut microbiota and the body's response to bacterial infection. The absence of this protein results in stronger defenses against intestinal infections, including increased production of short-chain fatty acids that promote an anti-inflammatory environment.
Researchers analyzed ancient DNA from an 8,000-year-old sheep bone and found evidence of Brucella melitensis, a pathogen causing significant harm to livestock. The study suggests that brucellosis evolved around the same time as farming development, with early farmers creating conditions for pathogen host-jumping.
Human lung organoids can form lifelike models for tuberculosis infection, enabling the testing of anti-tuberculosis drugs. These models may also facilitate the development of host-directed therapies.
A new study reveals that Cutibacterium acnes can persist in biofilms on implants for weeks, invading deep bone networks and causing chronic infections. The bacteria's ability to invade osteocyte lacuno-canalicular networks provides a novel mechanism for treating difficult-to-treat bone infections.
A study by Michigan State University reveals that certain proteins and peptides in the nasal and oral environments create lubricants for bacterial colonies to move towards vulnerable sites. The discovery provides new insights into how staphylococcus bacteria spread, shedding light on conditions that accelerate their movement.
A study by Dr. Takanori Sekito and colleagues reveals a strong association between vaginal pathogenic Escherichia coli and recurrent cystitis in postmenopausal women, suggesting that targeting both the urinary bladder and vagina is crucial for effective treatment.
Emerging antimicrobial resistance in Salmonella isolates found in retail chicken meat poses a significant threat to public health. The study found a dramatic increase in multidrug-resistant S. Infantis, which has been linked to high levels of antimicrobial resistance and virulence genes.
Researchers from Rice University discovered that viruses achieve precise timing in cell lysis by balancing the buildup and breakdown of holin proteins. This balance ensures optimal cell bursting, essential for viral replication, despite underlying randomness in biological processes.
Scientists from Hackensack Meridian Health have identified a new potential pathway for developing vaccines against tuberculosis by targeting marginal zone B (MZB) cells, a natural response to TB infection. The discovery suggests that boosting MZB cell activity could provide reliable and durable protection against the disease.
Researchers at Hokkaido University have developed a comprehensive derivative synthesis method to find new antimicrobial drugs. They identified eight analogs possessing strong MraY inhibitory and antibacterial activity, with one showing promising effectiveness in mouse infection models.
Researchers have discovered how Haemophilus influenzae turns off the body's immune responses to persist in respiratory tissues. The bacterium convinces the immune system there is no threat, inducing a state of tolerance, and can worsen symptoms in vulnerable groups like cystic fibrosis patients and asthma sufferers.
Research reveals native plants and non-native crops attract pests that spread diseases, causing harm to both plant populations. The studies also found viruses transmitted from crops to wild plants, which can have devastating effects on native ecosystems.
Researchers at Trinity College Dublin have made a breakthrough in understanding how to improve vaccine responses against the potentially deadly MRSA bacterium. By targeting the immune-suppressive molecule IL-10, they improved the ability of vaccines to protect against infection and reduce bacterial clearance.